VANCOUVER, British Columbia, April 9, 2002 (PRIMEZONE) -- Pyng Technologies Corp. (OTCBB:PYNGF) (CDNX:PYT) and subsidiary Pyng Medical Corp. are pleased to provide an update on sales of the F.A.S.T.1 System.
Pyng Medical Corp. has received and has expedited an order for 250 F.A.S.T.1 Systems plus training kits for immediate deployment with the 3rd Battalion, 1st Special Forces, (Airborne), from Ft. Lewis, Washington. This initial order was received and delivered out to the Airborne in late March. This adds another level to the Special Operations Forces, Military Hospitals and Military training sites that are active on the F.A.S.T.1 System.
Pyng Medical Corp. continues to penetrate the military market with hands on training generated from requests throughout the U.S.
In a previous news release, it was announced that on January 14, 2002, Pyng Medical Corp. trained twenty-six medics of the 3rd Battalion, 1st Special Forces (Airborne) at Ft. Lewis, Washington.
The Airborne medics now have the F.A.S.T.1 System for immediate use in the battlefield environment. They are also trained to be trainers on the F.A.S.T.1 System, and as such they are fully capable to go into the field and train other medics, in other Battalions, on the F.A.S.T.1 procedure. We are proud to have the F.A.S.T.1 System active in Afghanistan with the Special Forces Groups.
For information please visit our Web site at www.pyng.com or call 604-303-7964 or 1-800-349-7964.
The Canadian Venture Exchange has neither reviewed nor approved of the contents of this news release. Safe Harbor Statement: This release may contain certain forward-looking statements including without limitation, projections, assumptions, expectations, product development objectives, commercial introduction and potential advantages of the F.A.S.T.1 System. Actual events or results may differ from the Company's expectations as a result of risk factors discussed in Pyng Technologies Corp. reports on the file with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's report on Form 20F for the year ended September 30, 2001.